24 March 2024>: Clinical Research
Psychological and Physical Well-Being in Women Diagnosed with Breast Cancer: A Comprehensive Study of Anxiety, Depression, Sleep Quality, Physical Activity, and Sociodemographic Factors
Oliver J. Czech 1ABCDEFG* , Rafał Matkowski 23BEG , Jakub Skórniak 2BE , Iwona Malicka 1ABCDEFGDOI: 10.12659/MSM.943490
Med Sci Monit 2024; 30:e943490
Table 5 Results of regression for anxiety.
Variables | b | SE b | 95% CI | t | P | F | P | R2 | ΔR2 | |
---|---|---|---|---|---|---|---|---|---|---|
LL | UL | |||||||||
100.23 | 0.53 | 0.53 | ||||||||
Breast cancer | 18.43 | 1.84 | 14.77 | 22.09 | 10.01 | |||||
28.04 | 0.57 | 0.04 | ||||||||
Breast cancer | 16.86 | 1.94 | 13.01 | 20.71 | 8.71 | |||||
Sleep efficacy | −0.18 | 0.08 | −0.34 | −0.02 | −2.21 | |||||
PA level (sufficient) | −3.35 | 2.18 | −7.69 | 1.00 | −1.53 | 0.13 | ||||
PA level (high) | −1.69 | 2.43 | −6.53 | 3.14 | −0.70 | 0.49 | ||||
16.98 | 0.59 | 0.02 | ||||||||
Breast cancer | 8.57 | 4.85 | −1.08 | 18.22 | 1.77 | 0.08 | ||||
Sleep efficacy | −0.19 | 0.08 | −0.36 | −0.03 | −2.39 | 0.02 | ||||
PA level (sufficient) | −2.66 | 2.21 | −7.05 | 1.73 | −1.21 | 0.23 | ||||
PA level (high) | −1.65 | 2.41 | −6.44 | 3.14 | −0.69 | 0.50 | ||||
ER+ | 9.32 | 4.85 | −0.34 | 18.97 | 1.92 | 0.06 | ||||
PR+ | −1.21 | 3.72 | −8.62 | 6.19 | −0.33 | 0.75 | ||||
HER2+ | 5.09 | 3.80 | −2.47 | 12.65 | 1.34 | 0.18 | ||||
14.77 | 0.59 | 0.00 | ||||||||
Breast cancer | 8.96 | 4.93 | −0.84 | 18.76 | −1.82 | 0.07 | ||||
Sleep efficacy | −0.19 | 0.08 | −0.36 | −0.03 | −2.38 | 0.02 | ||||
PA level (sufficient) | −2.38 | 2.28 | −6.91 | 2.14 | −1.05 | 0.30 | ||||
PA level (high) | −1.39 | 2.47 | −6.30 | 3.52 | −0.56 | 0.58 | ||||
ER+ | 9.12 | 4.89 | −0.60 | 18.85 | 1.87 | 0.07 | ||||
PR+ | −1.36 | 3.75 | −8.82 | 6.10 | −0.36 | 0.72 | ||||
HER2+ | 4.78 | 3.86 | −2.90 | 12.46 | 1.24 | 0.22 | ||||
Age | 0.05 | 0.10 | −0.14 | 0.24 | 0.54 | 0.59 | ||||
SE – standard error; CI – confidence intervals; LL – lower limit; UL – upper limit; PA – physical activity; ER+ – positive estrogen receptor expression; PR+ – positive progesterone receptor expression; HER2+ – human epidermal growth factor receptor 2 positive breast cancer. |